Palvella Therapeutics (PVLA) FCF Margin Growth (3y) (2017 - 2024)
Palvella Therapeutics (PVLA) FCF Margin Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9,545.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.75 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -3,088.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4,612.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 14,060.00 |
| 10 | Palvella Therapeutics | 2.25 Bn | 1.93 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -198,566.00 |
| Dec 31, 2023 | -112,661.00 |
| Sep 30, 2023 | 21,089.00 |
| Jun 30, 2023 | 3,186.00 |
| Mar 31, 2023 | -42,082.00 |
| Dec 31, 2022 | -1.01 Mn |
| Sep 30, 2022 | -293,462.00 |
| Jun 30, 2022 | -682,773.00 |
| Mar 31, 2022 | -3,139.00 |
| Dec 31, 2021 | 147,016.00 |
| Sep 30, 2021 | -18,968.00 |
| Jun 30, 2021 | 406,374.00 |
| Mar 31, 2021 | -83,841.00 |
| Dec 31, 2020 | 42,627.00 |
| Sep 30, 2020 | -115,003.00 |
| Jun 30, 2020 | 28,858.00 |
| Mar 31, 2020 | -203,422.00 |
| Dec 31, 2019 | 16,779.00 |
| Sep 30, 2019 | 39,555.00 |
| Jun 30, 2019 | 35,599.00 |